Monte Rosa Insider Sale: Bowen Matthew’s Tax‑Driven Move Explained
Insider sale by Bowen Matthew at Monte Rosa Therapeutics shows a routine tax event, while CEO and executive trades signal long‑term confidence in the company’s molecular‑glue pipeline.
3 minutes to read